Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1419
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
10019.049
uM
inf
inf
1.0500 1.0500 0.0000 -0.0250
-0.1954
0.4626
AU565
HER2amp
Luminal
Purvalanol A
CDK1
CDK
5900.067
uM
inf
inf
0.9793 0.9793 0.0000 -0.0189
-0.4227
2.4324
BT-474
HER2amp
Luminal
GSK461364
PLK1
PLK
9163.001
uM
inf
inf
-0.9994 -0.9994 0.0000 0.4623
0.5005
0.5227
BT-20
TNBC
Basal A
Selumetinib
MEK
MAPK
11854.155
uM
inf
inf
0.9135 0.9135 0.0000 0.0714
0.3056
1.3396
BT-474
HER2amp
Luminal
JNK-IN-5A
JNK
JNK
12178.144
uM
inf
inf
0.6802 0.6802 0.0000 0.1793
-0.0043
0.7891
BT-20
TNBC
Basal A
PS-1145
IKK
NFKB
5904.065
uM
inf
inf
0.7615 0.7615 0.0000 0.0871
0.5385
1.1681
21MT-1
HER2amp
-
MG-132
Proteasome
Proteasome
14191.189
uM
inf
inf
-0.1161 -0.1161 0.0000 0.5482
0.5418
2.9704
184A1
NM
Basal
Vinorelbine
TUBB
TUBB
7787.018
uM
inf
inf
-0.9963 -0.9963 0.0000 0.4831
0.4499
0.3791
21MT-1
HER2amp
-
MG-132
Proteasome
Proteasome
14191.189
uM
inf
inf
-0.1161 -0.1161 0.0000 0.5482
0.5418
2.9704
AU565
HER2amp
Luminal
SB-3CT
MMP2/9
MMP
10880.144
uM
inf
inf
0.6825 0.6825 0.0000 0.0829
0.4632
1.8532
184A1
NM
Basal
(Z)-4-Hydroxytamoxifen
ESR1
9047.132
uM
inf
inf
0.4055 0.4055 0.0000 0.2074
0.3073
0.6985
BT-474
HER2amp
Luminal
Dichloroacetate
PDK
PDK
13125.176
uM
inf
inf
0.8740 0.8740 0.0000 0.0169
0.4953
0.8351
AU565
HER2amp
Luminal
JNK-IN-5A
JNK
JNK
10880.144
uM
inf
inf
0.6567 0.6567 0.0000 0.2741
0.4357
1.8532
BT-483
HR+
Luminal
PD184352
MEK
MAPK
10696.146
uM
inf
inf
0.6829 0.6829 0.0000 0.1390
0.0199
0.5009
BT-549
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
5910.098
uM
inf
inf
0.9455 0.9455 0.0000 -0.0163
0.2428
3.2046
BT-474
HER2amp
Luminal
PD184352
MEK
MAPK
12291.155
uM
inf
inf
0.8808 0.8808 0.0000 -0.0271
-0.2848
0.4532
21MT-1
HER2amp
-
Ribavirin
15382.211
uM
inf
inf
0.9683 0.9683 0.0000 0.0416
0.0000
1.1714
BT-549
TNBC
Basal B
AG1024
IGF1R
RTK
5910.066
uM
inf
inf
1.0203 1.0203 0.0000 -0.0416
-10.1657
3.0773
BT-474
HER2amp
Luminal
AS-252424
PI3K
PI3K
12178.158
uM
inf
inf
0.0271 0.0271 0.0000 0.1623
0.5062
0.7379
HCC1395
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7436.095
uM
inf
inf
0.9643 0.9643 0.0000 0.0131
0.0000
1.3597
BT-549
TNBC
Basal B
Methotrexate
DHFR
Metabolism
5909.085
uM
inf
inf
0.9298 0.9298 0.0000 -0.0072
0.3654
3.0853
CAMA-1
HR+
Luminal
Cetuximab
EGFR
ErbB
7805.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0217
-0.4906
1.1451
BT-20
TNBC
Basal A
PD184352
MEK
MAPK
10581.146
uM
inf
inf
0.7166 0.7166 0.0000 0.1279
0.5419
1.1650
HCC1954
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7454.095
uM
inf
inf
0.7171 0.7171 0.0000 0.1308
0.4162
1.1351
HCC1954
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7455.095
uM
inf
inf
-0.6708 -0.6708 0.0000 0.3794
0.1820
1.8461